Prevention of cytomegalovirus disease after heart transplantation: preemptive therapy with 7 days' intravenous ganciclovir

By Paniagua M.J.   Crespo-Leiro M.G.   De la Fuente L.   Tabuyo T.   Mosquera I.   Canizares A.   Naya C.   Farina P.   Juffe A.   Castro-Beiras A.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 69-70

Elsevier

Access to resources Recommend Favorite

Usefulness of quantitative Cytomegalovirus antigenemia determinations in heart transplantation

By Manito N.   Perez J.L.   Roca J.   Castells E.   Niubo J.   Garcia A.   Ribas M.   Saura E.   Ruf G.   Gomez-Hospital J.A.   Espinoza C.   Esplugas E.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2526-2527

Elsevier

Access to resources Recommend Favorite

Use of cytomegalovirus antigenemia as a marker for preemptive treatment

By Guirado L.   Herreros M.A.   Munoz J.M.   Rabella N.   Facundo C.   Agraz I.   Daz M.   Diaz J.M.   Duran F.   Sola R.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 67-68

Elsevier

Access to resources Recommend Favorite

Detection of Human Cytomegalovirus in Renal Transplantation: Comparison of Four Diagnostic Methods: DNA In Sera by Polymerase Chain Reaction (PCR), DNA in Leukocyte by PCR, pp65 Leukocytic Antigenemia, and Viremia

By Eckart P.   Brouard J.   Vabret A.   Freymuth F.   Guillot M.   Ryckelynck J.   Hurault de Ligny B.  

Transplantation Proceedings, Vol. 29, Iss. 5, 1997-08 ,pp. : 2387-2389

Elsevier

Access to resources Recommend Favorite

Comparison of antigenemia (pp65) assay and polymerase chain reaction in diagnosis of cytomegalovirus infection in renal transplant recipients treated with atg

By Durlik M.   Siennicka J.   Litwinska B.   Majchrzak J.   Paczek L.   Lao M.   Samsel R.   Chmura A.   Kantoch M.  

Transplantation Proceedings, Vol. 32, Iss. 6, 2000-09 ,pp. : 1350-1352

Elsevier

Access to resources Recommend Favorite